20/01/2026
Metabolic dysfunction-associated steatotic liver disease (MASLD)* a prevalent chronic liver condition, closely linked to metabolic dysfunction. It affects an estimated 30% of the global population.
The encouraging news? Carbohydrate-reduction strategies show significant promise in addressing the root metabolic drivers of MASLD
👉 Read more in our latest blog post.
Metabolic dysfunction-associated steatotic liver disease (MASLD)* is a common chronic liver disease that is strongly associated with metabolic dysfunction